Fulton Breakefield Broenniman LLC Abbott Laboratories Transaction History

Fulton Breakefield Broenniman LLC

$1.36 Billion
Q1 2025

A detailed history of Fulton Breakefield Broenniman LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 5,860 shares of ABT stock, worth $766,195. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,860

Previous 7,452 21.36%

Holding current value

$766,195

Previous $842,000 7.72%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$111.1 - $140.22 $176,871 - $223,230	-1,592 Reduced 21.36%	5,860 $777,000
Q4 2024 Jan 22, 2025	BUY	$111.93 - $119.39 $3,022 - $3,223	27 Added 0.36%	7,452 $842,000
Q3 2024 Oct 16, 2024	SELL	$100.07 - $118.13 $38,727 - $45,716	-387 Reduced 4.95%	7,425 $846,000
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $2,921 - $3,260	-29 Reduced 0.37%	7,812 $811,000
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $68,997 - $76,204	-630 Reduced 7.44%	7,841 $891,000
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $103,447 - $126,628	-1,147 Reduced 11.93%	8,471 $932,000
Q3 2023 Oct 20, 2023	SELL	$95.53 - $114.62 $34,390 - $41,263	-360 Reduced 3.61%	9,618 $931,000
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $155,906 - $173,712	-1,547 Reduced 13.42%	9,978 $1.09 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $259,875 - $305,888	-2,683 Reduced 18.88%	11,525 $1.17 Million
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $71,675 - $84,086	754 Added 5.6%	14,208 $1.56 Million
Q2 2022 Jul 28, 2022	BUY	$102.07 - $123.37 $1.37 Million - $1.66 Million	13,454 New	13,454 $1.46 Million
Q1 2022 Apr 27, 2022	SELL	$114.02 - $139.04 $308,880 - $376,659	-2,709 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $18,138 - $22,209	157 Added 6.15%	2,709 $381,000
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $43,747 - $48,397	-375 Reduced 12.81%	2,552 $301,000
Q2 2021 Jul 27, 2021	SELL	$105.79 - $124.53 $4,231 - $4,981	-40 Reduced 1.35%	2,927 $339,000
Q1 2021 Apr 09, 2021	BUY	$108.84 - $128.23 $15,999 - $18,849	147 Added 5.21%	2,967 $356,000
Q4 2020 Jan 14, 2021	SELL	$105.0 - $114.42 $9,135 - $9,954	-87 Reduced 2.99%	2,820 $309,000
Q3 2020 Oct 20, 2020	BUY	$91.64 - $111.29 $183 - $222	2 Added 0.07%	2,907 $316,000
Q2 2020 Jul 10, 2020	BUY	$76.57 - $98.0 $222,435 - $284,690	2,905 New	2,905 $266,000
Q1 2020 Apr 10, 2020	SELL	$62.82 - $91.86 $151,082 - $220,923	-2,405 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$81.84 - $88.74 $196,825 - $213,419	2,405 New	2,405 $201,000

Others Institutions Holding ABT

# of Institutions

3,464

Shares Held

1.34B

Call Options Held

10.5M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Account

Fulton Breakefield Broenniman LLC Abbott Laboratories Transaction History